Vinit Saxena

Mr. Vinit Saxena is the founder and CEO/ CTO of Sepragen Corporation, a company specializing in providing innovative and award-winning bio-processing equipment and consumables for the production and purification of biological drugs, high-end nutritional and dairy ingredients and vaccines. Sepragen's patented technologies are used globally in producing 35 FDA approved drugs including 100s of millions of doses of two approved and well known Covid-19 vaccines. Mr. Saxena’s industry experience spans over thirty-five (35) years including senior roles in development, marketing and manufacturing at leading life science suppliers and CMOs. Mr. Saxena is a graduate of IIT Kanpur, India and has an MS in Chemical Engineering from Syracuse University and an MBA from U.C. Berkeley. He has authored over 15 patents and several publications in the trade press and peer reviewed journals. He has been a featured presenter and chair at several industry conferences and panels. He is on the Scientific Advisory Board of The Keck Graduate Institute, Claremont, CA and served as adjunct faculty advisor to doctoral students. He is also the winner of several SBIR grants and the prestigious IR 100 award.